Menu
En Español
Call Us 24/7 for a FREE Consultation
888.650.0918

Diabetes Drug Makers Ordered To Pay $90 Million

The company behind the diabetes drug Avandia has been ordered to pay $90 million to settle allegations the drug company unlawfully promoted its drug.

GlaxoSmithKline was accused in February 2010 of hiding the risks associated with Avandia from the public. According to the report by the Senate Finance Committee, the drug was linked to tens of thousands of heart attacks, which the company knew about, but did not disclose. A study released in 2007 also found that the drug increased the risk of heart attack by 43 percent.

It has been estimated that Avandia caused between 60,000 and 200,000 heart attacks and deaths due to cardiovascular complications between 1999 and 2006. Avandia was also shown to cause liver toxicity, strokes and severe allergic reactions.

The $90 million will be divided among 37 states, including Florida.

Every year the list of recalled drug keeps growing. More often than we would like to think, prescription medications and even over-the-counter medications do more harm than good. A dangerous drug can be properly prescribed yet still cause serious personal injury, or even death, because of a defect in the way it was made.

It is widely reported that over 20 million people have at one time taken a drug that was eventually recalled, and billions of dollars are awarded to victims or surviving family members of those who were seriously injured or lost their life due to recalled drugs.

For more information about dangerous drugs, please contact us.

Source: CNN, "Makers of diabetes drug will pay $90 million," Nov. 15, 2012.

Categories

When You’ve Been Wronged, We Make it Right

To discuss your case with a professional who cares, call our team at (888) 650-0918 or fill out the form below.

  • Please enter your name.
  • This isn't a valid email address.
    Please enter your email address.
  • This isn't a valid phone number.
    Please enter your phone number.
  • Please make a selection.
  • Please enter a message.